In addition to lung development, roxadustat can relieve airway inflammation and protect against acute lung injury (ALI) by increasing heme oxygenase-1 (HO-1) expression and decreasing tumor necrosis factor-α and interleukin-1β production [62]. The gene discussed is HMOX1; the disease is acute lung injury.